Marvi Tariq

University of Alabama at Birmingham

Papers

1

Total Citations

2

H-Index

1

About

Dr. Marvi Tariq is a pioneering thoracic surgeon whose work sits at the intersection of infectious disease and minimally invasive surgery. Her research focuses on developing and refining robotic-assisted techniques for complex pulmonary infections, most notably pulmonary mucormycosis—a rapidly progressive and often fatal fungal disease in immunocompromised patients. Her landmark 2024 paper, "To Cut (Minimally Invasively) Is to Cure: Robotic Lobectomy for Pulmonary Mucormycosis," has already garnered 2 citations, establishing a new paradigm for surgical management. Dr. Tariq demonstrated that robotic lobectomy offers a safer, less invasive alternative to traditional thoracotomy or video-assisted thoracoscopic surgery (VATS), achieving complete resection while reducing morbidity. This work directly addresses the critical need for rapid, definitive treatment in immunosuppressed populations. Her contributions bridge the gap between advanced surgical robotics and infectious disease management, offering hope for patients with limited treatment options. Dr. Tariq’s innovative approach is reshaping how surgeons think about operating in infected, friable tissue, and her ongoing work promises to expand the role of minimally invasive techniques in high-risk thoracic infections.

Research Focus

Key Achievements

1
H-Index
1
Papers
2
Total Citations
2
Avg Citations/Paper
🏆 Most Cited Paper
To Cut (Minimally Invasively) Is to Cure: Robotic Lobectomy for Pulmonary Mucormycosis
2 citations · 2024
📈 Most Prolific Year: 2024 (1 Papers)
🤝 Key Collaborators: 1
🏛 Institutions: University of Alabama at Birmingham

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago